Department of Cell, Developmental and Cancer Biology; and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email:
Abramson Cancer Center; and Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; email:
Annu Rev Pathol. 2023 Jan 24;18:123-148. doi: 10.1146/annurev-pathmechdis-031621-024600. Epub 2022 Sep 21.
Pancreatic ductal adenocarcinoma (PDAC) features a prominent stromal microenvironment with remarkable cellular and spatial heterogeneity that meaningfully impacts disease biology and treatment resistance. Recent advances in tissue imaging capabilities, single-cell analytics, and disease modeling have shed light on organizing principles that shape the stromal complexity of PDAC tumors. These insights into the functional and spatial dependencies that coordinate cancer cell biology and the relationships that exist between cells and extracellular matrix components present in tumors are expected to unveil therapeutic vulnerabilities. We review recent advances in the field and discuss current understandings of mechanisms by which the tumor microenvironment shapes PDAC pathogenesis and therapy resistance.
胰腺导管腺癌(PDAC)的特征是明显的基质微环境,具有显著的细胞和空间异质性,这对疾病生物学和治疗耐药性有重要影响。组织成像能力、单细胞分析和疾病建模方面的最新进展揭示了组织学特征,这些特征决定了 PDAC 肿瘤基质的复杂性。这些对协调癌细胞生物学的功能和空间依赖性的见解,以及肿瘤中细胞与细胞外基质成分之间存在的关系的理解,有望揭示治疗弱点。我们回顾了该领域的最新进展,并讨论了肿瘤微环境影响 PDAC 发病机制和治疗耐药性的机制的现有认识。